In general, my laboratory looks at understanding how immune responses shape and are shaped by malignancies. Where possible, our hope is to exploit these weaknesses to improve patient outcomes by enhancing response to conventional, targeted or immunotherapeutics. Currently, the laboratory focuses primarily on pancreas and breast cancers.